GE to buy Xcellerex in latest biomanufacturing-focused investment
GE Healthcare has announced plans to buy US production tech firm Xcellerex, continuing its efforts to build its biomanufacturing offering.
Archives for March 8, 2012
UPDATE
GSK and AstraZeneca fund NMR studies in a bid to improve manufacturing QC
GlaxoSmithKline (GSK) and Astrazeneca have each funded new nuclear magnetic resonance (NMR) research at the University of Warwick, UK which could improve the QC process for drugsmakers.
BI builds contract biomanufacturing biz with €17m investment
Boehringer Ingelheim (BI) has expended its biomanufacturing offering in response to demand for early-phase development customers.